DUX4 and Facioscapulohumeral dystrophy: Both cell-permeable cAMP and catalytic active PKA were sufficient to reduce DUX4 expression and ZSCAN4 and TRIM43 mRNA levels [52] in primary FSHD patients’ muscle cells.